Phenyl-piperazine derivatives as serotonin reuptake inhibitors
US10844029B2 · kind B2 · utility
0Cited by
17References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 15, 2017 |
| Grant date | Nov 24, 2020 |
| Priority date | — |
| Expiry date | Jun 15, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D295/096
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The invention provides compounds represented by the general formula I wherein the substituents are defined in the application. The compounds are useful in the treatment of an affective disorder, including depression, anxiety disorders including general anxiety disorder and panic disorder and obsessive compulsive disorder.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.